Primary open-angle glaucoma (POAG) and ocular hypertension (OHT) can lead to progressive vision loss, and conventional eyedrops (CD) often result in medication wastage and premature bottle exhaustion, while the effectiveness of microdrops (MD) in real-world settings remains uncertain due to limited evidence. To address this gap, a study evaluated the intraocular pressure-lowering efficacy of microdrops delivered via the Nanodropper compared with conventional drops in 29 patients with POAG/OHT receiving monotherapy The study found that microdrops significantly reduced intraocular pressure by 1.6 mm Hg compared with 0.13 mm Hg with conventional drops.
The incidence of premature bottle exhaustion decreased from 83% with conventional drops to 17% with microdrops. Adverse events were reported in 83% of participants using conventional drops versus 62% with microdrops, and most participants…
